281208-97-7 Usage
Uses
Used in Pharmaceutical Industry:
2,6,7-Trichloro-quinoline-3-carbaldehyde is used as a key ingredient in the synthesis of various pharmaceutical compounds. Its unique reactivity, due to the chlorine substituents and the carbaldehyde group, makes it a valuable component in the development of new drugs and medicinal complexes.
Used in Organic Synthesis:
In the field of organic synthesis, 2,6,7-Trichloro-quinoline-3-carbaldehyde is employed as a versatile building block for the creation of a wide range of chemical structures. Its reactivity and functional groups allow for the formation of various derivatives, which can be further utilized in the synthesis of complex molecules and materials.
Used in Chemical Research:
2,6,7-Trichloro-quinoline-3-carbaldehyde is also used in chemical research as a model compound to study the effects of substituents on the reactivity and properties of quinoline derivatives. This helps in understanding the fundamental principles of organic chemistry and can guide the design of new compounds with desired characteristics.
Note: The specific applications mentioned above are based on the general properties of the compound and its potential uses in the fields of pharmaceuticals, organic synthesis, and chemical research. More specific applications may vary depending on the exact requirements of the industry or research project.
Check Digit Verification of cas no
The CAS Registry Mumber 281208-97-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,1,2,0 and 8 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 281208-97:
(8*2)+(7*8)+(6*1)+(5*2)+(4*0)+(3*8)+(2*9)+(1*7)=137
137 % 10 = 7
So 281208-97-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H4Cl3NO/c11-7-2-5-1-6(4-15)10(13)14-9(5)3-8(7)12/h1-4H
281208-97-7Relevant academic research and scientific papers
NON-PEPTIDE GLP-1 AGONISTS
-
Page/Page column 51, (2010/02/13)
Novel non-peptide GLP-1 agonists, pharmaceutical compositions comprising them, use of the non-peptide GLP-1 agonists for the preparation of pharmaceutical compositions and methods for the treatment and/or prevention of disorders and diseases wherein an ac
